Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_assertion type Assertion NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_head.
- NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_assertion description "[Moreover, pretreatment of U373 with a cSrc inhibitor (PP2), a PI3K inhibitor (LY294002), an ERK inhibitor (PD98059), or a p38 MAPK inhibitor (SB203580) but not a JNK inhibitor (SP600125) significantly reduced the magnolol-induced increases of p27/Kip1 protein levels and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_provenance.
- NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_assertion evidence source_evidence_literature NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_provenance.
- NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_assertion SIO_000772 23448150 NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_provenance.
- NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_assertion wasDerivedFrom befree-2016 NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_provenance.
- NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_assertion wasGeneratedBy ECO_0000203 NP1056631.RApp3VwGEbXOfD6W1OHEUo-quOA_KZ7wgXJfN0VojHEAo130_provenance.